NO992677L - Farmas°ytiske preparater og innretninger for deres administrasjon - Google Patents

Farmas°ytiske preparater og innretninger for deres administrasjon

Info

Publication number
NO992677L
NO992677L NO992677A NO992677A NO992677L NO 992677 L NO992677 L NO 992677L NO 992677 A NO992677 A NO 992677A NO 992677 A NO992677 A NO 992677A NO 992677 L NO992677 L NO 992677L
Authority
NO
Norway
Prior art keywords
hfc
container
carrier
administration
devices
Prior art date
Application number
NO992677A
Other languages
English (en)
Other versions
NO992677D0 (no
Inventor
Paul Mccarthy
Michael Goodman
Aake Lindahl
Original Assignee
Bioglan Ireland R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625171.5A external-priority patent/GB9625171D0/en
Priority claimed from GBGB9626449.4A external-priority patent/GB9626449D0/en
Application filed by Bioglan Ireland R & D Ltd filed Critical Bioglan Ireland R & D Ltd
Publication of NO992677D0 publication Critical patent/NO992677D0/no
Publication of NO992677L publication Critical patent/NO992677L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)

Abstract

Innretning for tilveiebringelse av farmasøytiske doser og som omfatter en beholder, som er fylt med et farmasøytisk preparat inkluderende et farmasøytisk aktivt middel i en oppløsning av flytendegjort l,l,l,2-tetrafluoretan (HFC-134a) eller l,l,l,2,3,3,3-heptafluorpropan (HFC-227), og en bærer. Bæreren kan være en farmasøytisk akseptabel alkohol, polyol, (poly)alkoksyderivat, fettsyrealkylester, polyalkylenglykol eller dimetylsulfoksyd. Innretningen omfatter ventilmidler som er anordnet for tilførsel av aerosoldoser av det nevnte farmasøytiske preparat til det ytre av beholderen, og i det minste en del av innretningen er fremstilt av en polyester.
NO992677A 1996-12-04 1999-06-02 Farmas°ytiske preparater og innretninger for deres administrasjon NO992677L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625171.5A GB9625171D0 (en) 1996-12-04 1996-12-04 Pharmaceutical compositions and devices for their administration
GBGB9626449.4A GB9626449D0 (en) 1996-12-20 1996-12-20 Pharmaceutical compositions and device for their administration
PCT/GB1997/003360 WO1998024420A1 (en) 1996-12-04 1997-12-04 Pharmaceutical compositions and devices for their administration

Publications (2)

Publication Number Publication Date
NO992677D0 NO992677D0 (no) 1999-06-02
NO992677L true NO992677L (no) 1999-07-15

Family

ID=26310542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992677A NO992677L (no) 1996-12-04 1999-06-02 Farmas°ytiske preparater og innretninger for deres administrasjon

Country Status (13)

Country Link
EP (1) EP1011646B1 (no)
JP (1) JP2001505171A (no)
KR (1) KR20000069275A (no)
AT (1) ATE301991T1 (no)
AU (1) AU726510B2 (no)
CA (1) CA2273835A1 (no)
DE (1) DE69734017T2 (no)
DK (1) DK1011646T3 (no)
ES (1) ES2244008T3 (no)
IE (1) IES970858A2 (no)
NO (1) NO992677L (no)
NZ (1) NZ336049A (no)
WO (1) WO1998024420A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (en) * 1999-09-11 2008-03-19 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
GB2388843B (en) * 1999-09-11 2004-03-03 Glaxo Group Ltd A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
DK1280515T3 (da) 2000-03-09 2007-06-11 Gw Pharma Ltd Farmaceutiske sammensætninger omfattende cannabis
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
GB0015361D0 (en) * 2000-06-22 2000-08-16 Pharmasol Ltd Improvements in pharmaceutical compositions
WO2001097780A2 (en) * 2000-06-22 2001-12-27 Pharmasol Ltd Pharmaceutical compositions comprising an opioid analgesic
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
JP2005514437A (ja) * 2001-12-21 2005-05-19 スリーエム イノベイティブ プロパティズ カンパニー イオン対複合体を含む医薬用エアロゾル製剤
EP1321159A1 (en) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7255102B2 (en) 2002-02-01 2007-08-14 Generex Pharmaceuticals Inc. Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR100776770B1 (ko) * 2006-07-18 2007-11-29 (주)비엔에프 고압분사 에어로졸 밸브
US8578942B2 (en) * 2010-05-25 2013-11-12 British American Tobacco (Investments) Limited Aerosol generator
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
RU2541312C2 (ru) * 2011-08-31 2015-02-10 Александр Васильевич Иващенко Фармацевтическая композиция, способ ее получения и устройство для ее применения
JP6166453B2 (ja) * 2015-12-28 2017-07-19 花王株式会社 エアゾール化粧料
GB201912686D0 (en) * 2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition
KR102726961B1 (ko) * 2022-12-13 2024-11-06 주식회사 대웅제약 비강용 투약장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6907687A (en) * 1986-02-18 1987-08-20 Rorer Pharmaceutical Corporation Composition for treatment of asthmatic conditions using phenoxymethyl quinolines
ATE114112T1 (de) * 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
ATE339952T1 (de) * 1991-06-10 2006-10-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
FR2705570B1 (fr) * 1993-05-25 1995-07-13 Adir Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
TR199701170T1 (xx) * 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
GB9517998D0 (en) * 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration

Also Published As

Publication number Publication date
JP2001505171A (ja) 2001-04-17
WO1998024420A1 (en) 1998-06-11
DK1011646T3 (da) 2005-09-19
NZ336049A (en) 2000-09-29
DE69734017T2 (de) 2006-06-14
ES2244008T3 (es) 2005-12-01
CA2273835A1 (en) 1998-06-11
NO992677D0 (no) 1999-06-02
IES80485B2 (en) 1998-08-12
ATE301991T1 (de) 2005-09-15
EP1011646B1 (en) 2005-08-17
AU5402898A (en) 1998-06-29
KR20000069275A (ko) 2000-11-25
DE69734017D1 (de) 2005-09-22
EP1011646A1 (en) 2000-06-28
IES970858A2 (en) 1998-08-12
AU726510B2 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
NO992677L (no) Farmas°ytiske preparater og innretninger for deres administrasjon
US6413496B1 (en) Pharmaceutical compositions and devices for their administration
WO2001043722A3 (en) Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
ES2074124T3 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
CA2353847A1 (en) Pulmonary drug delivery
KR910007512A (ko) 국소 약제 가압에어로졸 조성물 및 그를 함유한 에어로졸 콘테이너의 제조방법
PT731688E (pt) Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
CA2004598A1 (en) Medicinal aerosol formulations
AU601176B2 (en) Benzodiazepine aerosols
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
BR9913154A (pt) Composição de musse
GB2332372B (en) Pharmaceutical aerosol compositions
IL129300A0 (en) A liquid pharmaceutical composition comprising an HIV protease inhibitor or a combination of HIV protease inhibitors in a pharmaceutically acceptable organic solvent
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
GB1114313A (en) Pharmaceutical compositions
PE20020055A1 (es) Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application